Detalhe da pesquisa
1.
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
N Engl J Med
; 383(24): 2333-2344, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085857
2.
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Ann Rheum Dis
; 81(5): 653-661, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264321
3.
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.
Rheumatology (Oxford)
; 61(7): 2915-2922, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718434
4.
Case 18-2023: A 19-Year-Old Woman with Dyspnea and Tachypnea.
N Engl J Med
; 388(24): 2275-2286, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314709
5.
Treatment failure in giant cell arteritis.
Ann Rheum Dis
; 80(11): 1467-1474, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049857
6.
Trial of Tocilizumab in Giant-Cell Arteritis.
N Engl J Med
; 377(4): 317-328, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28745999
7.
Case 3-2021: A 48-Year-Old Man with Transient Vision Loss.
N Engl J Med
; 384(4): 363-372, 2021 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33503346
8.
Case Records of the Mass General Hospital. Case 7-2015: A 25-year-old man with oral ulcers, rash, and odynophagia.
N Engl J Med
; 372(9): 864-72, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25714165
9.
Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis.
RMD Open
; 9(2)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024237
10.
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis.
Arthritis Res Ther
; 25(1): 199, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840134
11.
The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial.
Rheumatol Ther
; 9(2): 497-508, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954809
12.
Ustekinumab for the Treatment of Giant Cell Arteritis.
Arthritis Care Res (Hoboken)
; 73(6): 893-897, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32248659
13.
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial.
Semin Arthritis Rheum
; 51(2): 469-476, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33784598
14.
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial.
Lancet Rheumatol
; 3(5): e328-e336, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279390
15.
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis.
Rheumatol Ther
; 7(4): 793-810, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32844378
16.
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.
Arthritis Rheumatol
; 71(8): 1329-1338, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30835950
17.
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.
Semin Arthritis Rheum
; 46(5): 657-664, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27998620
18.
Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients.
RMD Open
; 3(2): e000570, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29299342
19.
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Arthritis Care Res (Hoboken)
; 69(7): 1004-1010, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696762
20.
Reply.
Arthritis Care Res (Hoboken)
; 73(7): 1059-1060, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33161642